Dali Pharmaceutical (603963)

Dali Pharmaceutical (603963)

$ 90

ESG +3

English Version

Date : 31 Jul 2020


Dali Pharmaceutical Co., Ltd. is a China-based company principally involved in the production and sales of Chinese and western medicine injections. The Company’s main products include Xingnaojing injections and Shenmai injections. The other products include astragalus injections and mycorrhizal injections. Through its subsidiaries, the Company is also involved in the lease of offices and factory buildings, as well as the investment of equity.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner